
XyloCor Therapeutics
Focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease.
Employees
Enterprise value
$270—405m
Authorizing premium user...
Focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease.